L’Oréal’s Potential Acquisition of Innovist: A Strategic Move in D2C Personal Care

L’Oréal, a leading name in beauty and cosmetics, is in advanced negotiations to secure a majority stake in Innovist, a direct-to-consumer (D2C) personal care startup, as reported by Moneycontrol. Innovist is the parent company to popular brands such as Bare Anatomy, Chemist at Play, Sunscoop, and Vinci Botanicals.

Details of the Proposed Deal

The anticipated acquisition is projected to value Innovist between $350 million and $450 million, which translates to approximately Rs 3,240–4,170 crore. This strategic move comes as L’Oréal aims to reinforce its presence in the Indian market. Reports indicate that L’Oréal plans to start by obtaining a controlling interest in Innovist, with plans to gradually escalate its ownership to 100% over the coming years.

The D2C Beauty Landscape in India

The D2C beauty and wellness sector in India has seen a significant surge in strategic acquisitions and consolidations recently. Major FMCG corporations are keen to integrate digitally native brands that have established strong recognition among consumers. For instance, Hindustan Unilever Limited made headlines by acquiring the remaining 49% stake in Oziva for Rs 824 crore, adding to its previous investments.

In another notable transaction, pharmaceutical giant USV secured a 79% stake in Wellbeing Nutrition. Similarly, Mumbai-based Marico has invested in the health sector by acquiring a 60% stake in the plant-based protein startup Cosmix, with an equity valuation of Rs 375 crore.

Continued Trends in Consolidation

This current trend builds upon last year’s notable consolidations, including HUL’s acquisition of the skincare brand Minimalist at a pre-money valuation of Rs 2,955 crore. If the L’Oréal and Innovist deal proceeds at the cited valuation, it will surpass the size of the HUL and Minimalist deal, highlighting the ongoing evolution of the beauty and personal care market in India.